NDC product
Caffeine and Sodium Benzoate
NDC 0517-2502 · American Regent, Inc.
Key facts
| Product NDC | 0517-2502 |
|---|---|
| Proprietary name | Caffeine and Sodium Benzoate |
| Nonproprietary name | Caffeine and Sodium Benzoate |
| Substances | CAFFEINE |
| Dosage form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR, INTRAVENOUS |
| Labeler | American Regent, Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Pharmacologic classes | Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS] |
| Marketing start | Feb 1, 1993 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: